Found: 81
Select item for more details and to access through your institution.
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Phase II Trials in Small-Cell Lung Cancer: Shouldn't We Be Doing Better?
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 14, p. 1058
- By:
- Publication type:
- Article
Dose-Ranging Trial of Zacopride: The Emetic Antiemetic?
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 9, p. 717
- By:
- Publication type:
- Article
Phase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by Cisplatin.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 1, p. 42
- By:
- Publication type:
- Article
Management of Lung Cancer in Older Adults.
- Published in:
- CA: A Cancer Journal for Clinicians, 2003, v. 53, n. 6, p. 325, doi. 10.3322/canjclin.53.6.325
- By:
- Publication type:
- Article
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.
- Published in:
- Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33719-6
- By:
- Publication type:
- Article
Lung Cancer in US Women: A Contemporary Epidemic.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 14, p. 1763, doi. 10.1001/jama.291.14.1763
- By:
- Publication type:
- Article
Predictors of Clinical Response of Non–Small Cell Cancer to Gefitinib—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 13, p. 1563, doi. 10.1001/jama.291.13.1563-b
- By:
- Publication type:
- Article
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 16, p. 2149, doi. 10.1001/jama.290.16.2149
- By:
- Publication type:
- Article
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1253629
- By:
- Publication type:
- Article
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Acute chest pain syndrome during bleomycin infusions.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 475, doi. 10.1016/j.cllc.2014.08.001
- By:
- Publication type:
- Article
Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 405, doi. 10.1016/j.cllc.2014.06.002
- By:
- Publication type:
- Article
Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43172-8
- By:
- Publication type:
- Article
The New Era in Lung Cancer Care.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 8, p. 302, doi. 10.46883/onc.3408.302
- By:
- Publication type:
- Article
Cisplatin Versus Carboplatin for Patients With Metastatic Non-Small-Cell Lung Cancer—An Old Rivalry Renewed.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 828, doi. 10.1093/jnci/djk222
- By:
- Publication type:
- Article
Predicting Sensitivity of Non—Small-Cell Lung Cancer to Gefitinib: Is There a Role for P-Akt?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1117, doi. 10.1093/jnci/djh244
- By:
- Publication type:
- Article
Variations in Lung Cancer Risk Among Smokers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 6, p. 470, doi. 10.1093/jnci/95.6.470
- By:
- Publication type:
- Article
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.
- Published in:
- 1994
- By:
- Publication type:
- journal article
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasone.
- Published in:
- Cancer (0008543X), 1993, v. 72, n. S11, p. 3436, doi. 10.1002/1097-0142(19931201)72:11+<3436::AID-CNCR2820721610>3.0.CO;2-Z
- By:
- Publication type:
- Article
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 134, doi. 10.1093/neuonc/noaa152
- By:
- Publication type:
- Article
“Pulsatile” high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 12, p. 1364, doi. 10.1093/neuonc/nor121
- By:
- Publication type:
- Article
Phase 1 Trial of Everolimus and Gefitinib in Patients With Advanced Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 599, doi. 10.1002/cncr.22816
- By:
- Publication type:
- Article
A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancerPresented in part at the 2004 American Society of Clinical Oncology Meeting, New Orleans, Louisiana, June 5–8, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1034
- By:
- Publication type:
- Article
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 10, p. 2149
- By:
- Publication type:
- Article
Developing a cancer‐specific geriatric assessmentPresented at the 40th annual meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 5–8, 2004.: A feasibility study.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 9, p. 1998, doi. 10.1002/cncr.21422
- By:
- Publication type:
- Article
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 11, p. 2344, doi. 10.1002/cncr.21033
- By:
- Publication type:
- Article
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinomaPresented at the 45th annual meeting of the American Society of Therapeutic Radiology and Oncology, Salt Lake City, Utah, October 20, 2003.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2118
- By:
- Publication type:
- Article
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein: A Phase II clinical trial.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2128
- By:
- Publication type:
- Article
The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 1, p. 119, doi. 10.1002/cncr.10628
- By:
- Publication type:
- Article
Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.
- Published in:
- Supportive Care in Cancer, 2010, v. 18, n. 4, p. 509, doi. 10.1007/s00520-009-0744-x
- By:
- Publication type:
- Article
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 16078, doi. 10.1038/ncomms16078
- By:
- Publication type:
- Article
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1079, doi. 10.1007/s00280-010-1265-5
- By:
- Publication type:
- Article
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 833, doi. 10.1007/s00280-009-1088-4
- By:
- Publication type:
- Article
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 67, doi. 10.1007/s00280-009-1003-z
- By:
- Publication type:
- Article
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 467, doi. 10.1007/s00280-006-0286-6
- By:
- Publication type:
- Article